Cholesteryl Ester Transfer Protein: Pharmacological Inhibition for the Modulation of Plasma Cholesterol Levels and Promising Target for the Prevention of Atherosclerosis.

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 3, 2005-04 ,pp. : 257-264

Bentham Science Publishers

Access to resources Recommend Favorite

Raising high-density lipoprotein cholesterol with inhibitors of cholesteryl ester transfer protein – a new approach to coronary artery disease

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1365-1368

Informa Healthcare

Access to resources Recommend Favorite

HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent ''direct'' effects on atherosclerotic vessels in high cholesterol diet-fed rabbits

By Mitani H.   Egashira K.   Kimura M.  

Pharmacological Research, Vol. 48, Iss. 5, 2003-11 ,pp. : 417-427

Elsevier

Access to resources Recommend Favorite

Effect of JTT-705 on cholesteryl ester transfer protein and plasma lipid levels in normolipidemic animals

By Okamoto H.   Iwamoto Y.   Maki M.   Sotani T.   Yonemori F.   Wakitani K.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 147-154

Elsevier

Access to resources Recommend Favorite

Cholesteryl ester transfer protein inhibitors

By Shinkai H.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 739-745

Informa Healthcare

Access to resources Recommend Favorite